Renée Bazin Selected Research

Infections

1/2022	Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection.
1/2022	Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
1/2022	SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses.
5/2021	Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
1/2021	High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.
10/2020	Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.
7/2020	Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike.
10/2007	Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renée Bazin Research Topics

Disease

9	COVID-19 06/2022 - 10/2020
8	Infections 01/2022 - 10/2007
7	Autoimmune Diseases (Autoimmune Disease) 02/2014 - 10/2004
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2013 - 10/2004
5	Thrombocytopenia (Thrombopenia) 08/2013 - 10/2006
3	Inflammation (Inflammations) 03/2022 - 05/2016
2	Coinfection 01/2021 - 01/2021
2	Convalescence 01/2021 - 01/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2015 - 09/2014
2	Alzheimer Disease (Alzheimer's Disease) 03/2014 - 12/2013
1	Multiple Organ Failure (MODS) 03/2022
1	Transfusion Reaction 05/2021
1	Sepsis (Septicemia) 01/2017
1	Memory Disorders (Memory Loss) 03/2014
1	Parkinson Disease (Parkinson's Disease) 10/2012
1	Hypersensitivity (Allergy) 10/2009
1	Bacterial Infections (Bacterial Infection) 10/2007

Drug/Important Bio-Agent (IBA)

16	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 10/2004
7	AntibodiesIBA 01/2022 - 03/2007
6	Immunoglobulin G (IgG)IBA 01/2022 - 05/2005
5	VaccinesIBA 01/2022 - 10/2020
5	Inosine Triphosphate (ITP)IBA 02/2013 - 10/2004
2	Oxygen (Dioxygen)IBA 11/2021 - 05/2021
2	Neutralizing AntibodiesIBA 10/2020 - 07/2020
2	Antigen-Antibody Complex (Immune Complex)IBA 02/2013 - 10/2006
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Viral AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 05/2021
1	Bisoprolol (Concor)FDA LinkGeneric 05/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2016
1	Therapeutic UsesIBA 02/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2012
1	NeurotoxinsIBA 10/2012
1	AntigensIBA 12/2011
1	Interferon-gamma (Interferon, gamma)IBA 10/2007
1	LipopolysaccharidesIBA 10/2007
1	CytokinesIBA 03/2007
1	Rho(D) Immune Globulin (RhoGAM)IBA 03/2007
1	Monoclonal AntibodiesIBA 10/2006
1	AutoantibodiesIBA 05/2005

Therapy/Procedure

2	Therapeutics 01/2021 - 08/2013
1	Blood Transfusion (Blood Transfusions) 06/2022
1	Length of Stay 05/2021
1	Critical Care (Surgical Intensive Care) 05/2021
1	Mechanical Ventilators (Ventilator) 05/2021
1	Immunomodulation 05/2016
1	Transplantation 06/2015
1	Stem Cell Transplantation 09/2014
1	Immunotherapy 10/2012